July 18, 2016 / 8:37 PM / a year ago

BRIEF-Helix Biopharma announces deal with National Research Council of Canada

July 18 (Reuters) - Helix Biopharma Corp

* Helix Biopharma announces agreement in principle with National Research Council of Canada to collaborate on various immuno-oncology initiatives

* Agreement spells out framework to enable Helix to finalize master agreement with NRC to develop new therapeutics for cancer immunotherapies

* Agreement allows for discussion on a potential license of antibody previously obtained from NRC under a material transfer agreement Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below